共 9 条
[1]
Increased proteasom-dependent degradation of cyclin -dependant kinase inhibitor p27 in aggressive colorectal carcinoma. Loda M,Cnker B,Tam SW,et al. Nature Medicine . 1997
[2]
Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases. Thomas GV,Szigeti K,Murphy M,et al. American Journal of Pathology . 1998
[3]
Cyclins and cancer Ⅱ: cyclin-D and CDK inhibitors come of age. Hunter T,Pines J. Cell . 1994
[4]
Increased proteasoma-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Loda M,Cukor B,Tam SW,et al. Nature Medicine . 1997
[5]
Cloning of p27 kipl , a cyclin-dependent kinase inhibitor and a potential mediator of extracelluar antimitogenic signals. Polyak K,lee MH,Erdijument -Bromage H,et al. Cell . 1994
[6]
p27 kipl in human lung cancers: differential changes in small cell and non-small cell carcinoma. Yatabe Y,Masuda A,Koshikawa T,et al. Cancer Research . 1998
[7]
High level expression of p27 ( kipl ) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27( kipl ) and degree of malignancy in human breast and colorectal cancers. Fredersdorf S,Burns J,Milne AM,et al. Proceedings of the National Academy of Sciences of the United States of America . 1997
[8]
The cell cycle inhibitor p27 is an independent prognostic marker in small invasive breast carcinoma. Tan P,Cady B,Wanner M,et al. Cancer Research . 1997
[9]
Prognostic role of the cyclindependent kinase inhibitor p27 in non-small cell lung cancer. Esposito V,Baldi A,Deluca,et al. Cancer Research . 1997